Recruitment of classical monocytes can be inhibited by disturbing heteromers of neutrophil HNP1 and platelet CCL5

Science Translational Medicine

Volumn 7, Issue 317, 2015, Pages

  Alard, Jean Eric ^a   Ortega Gomez, Almudena ^a   Wichapong, Kanin ^b   Bongiovanni, Dario ^c   Horckmans, Michael ^a   Megens, Remco T A ^a,b   Leoni, Giovanna ^a   Ferraro, Bartolo ^a,d   Rossaint, Jan ^e   Paulin, Nicole ^a   Ng, Judy ^c   Ippel, Hans ^b   Suylen, Dennis ^b   Hinkel, Rabea ^a,c,f   Blanchet, Xavier ^a   Gaillard, Fanny ^g   D'Amico, Michele ^d   Von Hundelshausen, Phillipp ^a   Zarbock, Alexander ^e   Scheiermann, Christoph ^a   Hackeng, Tilman M ^b   Steffens, Sabine ^a,f   Kupatt, Christian ^c,f   Nicolaes, Gerry A F ^b   Weber, Christian ^a,b,f   Soehnlein, Oliver ^a,f,h   more..

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e UNIVERSITY OF MÜNSTER   (Germany)

^f DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^g STATION BIOLOGIQUE   (France)

^h ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; CHEMOKINE RECEPTOR CCR5; HETEROMER; HUMAN NEUTROPHIL PEPTIDE 1; MULTIPROTEIN COMPLEX; RANTES; UNCLASSIFIED DRUG; PROTEIN BINDING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG TARGETING; HEART INFARCTION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ADHERENCE; LEUKOCYTE FUNCTION; MACROPHAGE ACTIVATION; METABOLIC INHIBITION; MONOCYTE RECRUITMENT; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; PROTEIN STRUCTURE; CARDIAC MUSCLE; CELL ADHESION; CYTOLOGY; METABOLISM; MONOCYTE; NEUTROPHIL; PROTEIN MULTIMERIZATION; THROMBOCYTE; UMBILICAL VEIN ENDOTHELIAL CELL;

ALPHA-DEFENSINS; BLOOD PLATELETS; CELL ADHESION; CHEMOKINE CCL5; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MONOCYTES; MYOCARDIUM; NEUTROPHILS; PROTEIN BINDING; PROTEIN MULTIMERIZATION;

EID: 84954431664     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aad5330     Document Type: Article

References (40)

1. J. W. Conlan, R. J. North, Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J. Exp. Med. 179, 259-268 (1994).
2. A. Chalaris, B. Rabe, K. Paliga, H. Lange, T. Laskay, C. A. Fielding, S. A. Jones, S. Rose-John, J. Scheller, Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils. Blood 110, 1748-1755 (2007).
3. O. Soehnlein, A. Zernecke, E. E. Eriksson, A. G. Rothfuchs, C. T. Pham, H. Herwald, K. Bidzhekov, M. E. Rottenberg, C. Weber, L. Lindbom, Neutrophil secretion products pave the way for inflammatory monocytes. Blood 112, 1461-1471 (2008).
4. M. Drechsler, R. T. A. Megens, M. Van Zandvoort, C. Weber, O. Soehnlein, Hyperlipidemiatriggered neutrophilia promotes early atherosclerosis. Circulation 122, 1837-1845 (2010).
5. O. Soehnlein, L. Lindbom, C. Weber, Mechanisms underlying neutrophil-mediated monocyte recruitment. Blood 114, 4613-4623 (2009).
6. P. A. Ward, Chemotaxis of mononuclear cells. J. Exp. Med. 128, 1201-1221 (1968).
7. J. I. Gallin, M. P. Fletcher, B. E. Seligmann, S. Hoffstein, K. Cehrs, N. Mounessa, Human neutrophilspecific granule deficiency: A model to assess the role of neutrophil-specific granules in the evolution of the inflammatory response. Blood 59, 1317-1329 (1982).
8. A. F. Gombart, H. P. Koeffler, Neutrophil specific granule deficiency and mutations in the gene encoding transcription factor C/EBPε. Curr. Opin. Hematol. 9, 36-42 (2002).
9. O. Chertov, H. Ueda, L. L. Xu, K. Tani, W. J. Murphy, J. M. Wang, O. M. Z. Howard, T. J. Sayers, J. J. Oppenheim. Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J. Exp. Med. 186, 739-747 (1997).
10. M. C. Territo, T. Ganz, M. E. Selsted, R. Lehrer, Monocyte-chemotactic activity of defensins from human neutrophils. J. Clin. Invest. 84, 2017-2020 (1989).
11. A. Vieira-de-Abreu, R. A. Campbell, A. S. Weyrich, G. A. Zimmerman, Platelets: Versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin. Immunopathol. 34, 5-30 (2012).
12. J. M. Burkhart M. Vaudel, S. Gambaryan, S. Radau, U. Walter, L. Martens, J. Geiger, A. Sickmann, R. P. Zahedi, The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood 120, e73-e82 (2012).
13. T. Baltus, P. Von Hundelshausen, S. F. Mause, W. Buhre, R. Rossaint, C. Weber, Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions. J. Leukoc. Biol. 78, 435-441 (2005).
14. J. Bernhagen, R. Krohn, H. Lue, J. L. Gregory, A. Zernecke, R. R. Koenen, M. Dewor, I. Georgiev, A. Schober, L. Leng, T. Kooistra, G. Fingerle-Rowson, P. Ghezzi, R. Kleemann, S. R. McColl, R. Bucala, M. J. Hickey, C. Weber, MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat. Med. 13, 587-596 (2007).
15. E. Karshovska, C. Weber, P. Von Hundelshausen, Platelet chemokines in health and disease. Thromb. Haemost. 110, 894-902 (2013).
16. O. Soehnlein, M. Drechsler, Y. Döring, D. Lievens, H. Hartwig, K. Kemmerich, A. Ortega-Gómez, M. Mandl, S. Vijayan, D. Projahn, C. D. Garlichs, R. R. Koenen, M. Hristov, E. Lutgens, A. Zernecke, C. Weber, Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes. EMBO Mol. Med. 5, 471-481 (2013).
17. B. Passlick, D. Flieger, H. W. Ziegler-Heitbrock. Identification and characterization of a novel monocyte subpopulation in human peripheral blood. Blood 74, 2527-2534 (1989).
18. F. Geissmann, S. Jung, D. R. Littman. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71-82 (2003).
19. C. Varol, A. Mildner, S. Jung. Macrophages: Development and tissue specialization. Annu. Rev. Immunol. 33, 643-675 (2015).
20. C. Auffray, D. Fogg, M. Garfa, G. Elain, O. Join-Lambert, S. Kayal, S. Sarnacki, A. Cumano, G. Lauvau, F. Geissmann. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317, 666-670 (2007).
21. D. Rittirsch, M. A. Flierl, P. A. Ward, Harmful molecular mechanisms in sepsis. Nat. Rev. Immunol. 8, 776-787 (2008).
22. F. K. Swirski, M. Nahrendorf, Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science 339, 161-166 (2013).
23. S. Wantha, J.-E. Alard, R. T. A. Megens, A. M. Van Der Does, Y. Döring, M. Drechsler, C. T. N. Pham, M.-W. Wang, J.-M. Wang, R. L. Gallo, P. Von Hundelshausen, L. Lindbom, T. Hackeng, C. Weber, O. Soehnlein, Neutrophil-derived cathelicidin promotes adhesion of classical monocytes. Circ. Res. 112, 792-801 (2013).
24. P. B. Eisenhauer, R. I. Lehrer, Mouse neutrophils lack defensins. Infect. Immun. 60, 3446-3447 (1992).
25. P. Von Hundelshausen, K. S. C. Weber, Y. Huo, A. E. I. Proudfoot, P. J. Nelson, K. Ley, C. Weber, RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation 103, 1772-1777 (2001).
26. O. Soehnlein, X. Xie, H. Ulbrich, E. Kenne, P. Rotzius, H. Flodgaard, E. E. Eriksson, L. Lindbom, Neutrophil-derived heparin-binding protein (HBP/CAP37) deposited on endothelium enhances monocyte arrest under flow conditions. J. Immunol. 174, 6399-6405 (2005).
27. R. Chèvre, J. M. González-Granado, R. T. A. Megens, V. Sreeramkumar, C. Silvestre-Roig, P. Molina-Sánchez, C. Weber, O. Soehnlein, A. Hidalgo, V. Andrés. High-resolution imaging of intravascular atherogenic inflammation in live mice. Circ. Res. 114, 770-779 (2014).
28. S. Epelman, P. P. Liu, D. L. Mann, Role of innate and adaptive immune mechanisms in cardiac injury and repair. Nat. Rev. Immunol. 15, 117-129 (2015).
29. M. Nahrendorf, F. K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger, J.-L. Figueiredo, P. Libby, R. Weissleder, M. J. Pittet. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037-3047 (2007).
30. Y. Makino, D. N. Cook, O. Smithies, O. Y. Hwang, E. G. Neilson, L. A. Turka, H. Sato, A. D. Wells, T. M. Danoff, Impaired T cell function in RANTES-deficient mice. Clin. Immunol. 102, 302-309 (2002).
31. J. W. Tyner, O. Uchida, N. Kajiwara, E. Y. Kim, A. C. Patel, M. P. O'Sullivan, M. J. Walter, R. A. Schwendener, D. N. Cook, T. M. Danoff, M. J. Holtzman, CCL5-CCR5 interaction provides antiapoptotic signals for macrophage survival during viral infection. Nat. Med. 11, 1180-1187 (2005).
32. L. N. Sørensen, S. R. Paludan, Blocking CC chemokine receptor (CCR) 1 and CCR5 during herpes simplex virus type 2 infection in vivo impairs host defence and perturbs the cytokine response. Scand. J. Immunol. 59, 321-333 (2004).
33. H.-J. Anders, M. Frink, Y. Linde, B. Banas, M. Wörnle, C. D. Cohen, V. Vielhauer, P. J. Nelson, H.-J. Gröne, D. Schlöndorff, CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J. Immunol. 170, 5658-5666 (2003).
34. P. E. Westerweel, T. J. Rabelink, M. B. Rookmaaker, H.-J. Gröne, M. C. Verhaar, RANTES is required for ischaemia-induced angiogenesis, which may hamper RANTES-targeted antiatherosclerotic therapy. Thromb. Haemost. 99, 794-795 (2008).
35. + T cells. Blood 97, 1144-1146 (2001).
36. T. Baltus, K. S. C. Weber, Z. Johnson, A. E. I. Proudfoot, C. Weber, Oligomerization of RANTES is required for CCR1-mediated arrest but not CCR5-mediated transmigration of leukocytes on inflamed endothelium. Blood 102, 1985-1988 (2003).
37. P. Von Hundelshausen, R. R. Koenen, M. Sack, S. F. Mause, W. Adriaens, A. E. I. Proudfoot, T. M. Hackeng, C. Weber, Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 105, 924-930 (2005).
38. M. Schiraldi, A. Raucci, L. M. Muñoz, E. Livoti, B. Celona, E. Venereau, T. Apuzzo, F. De Marchis, M. Pedotti, A. Bachi, M. Thelen, L. Varani, M. Mellado, A. Proudfoot, M. E. Bianchi, M. Uguccioni, HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J. Exp. Med. 209, 551-563 (2012).
39. K. Wichapong, A. Rohe, C. Platzer, I. Slynko, F. Erdmann, M. Schmidt, W. Sippl, Application of docking and QM/MM-GBSA rescoring to screen for novel Myt1 kinase inhibitors. J. Chem. Inf. Model. 54, 881-893 (2014).
40. C. Blanpain, V. Wittamer, J.-M. Vanderwinden, A. Boom, B. Renneboog, B. Lee, E. Le Poul, L. El Asmar, C. Govaerts, G. Vassart, R. W. Doms, M. Parmentier, Palmitoylation of CCR5 is critical for receptor trafficking and efficient activation of intracellular signaling pathways. J. Biol. Chem. 276, 23795-23804 (2001).